scholarly journals Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials

2016 ◽  
Vol 36 (3) ◽  
pp. 403-415 ◽  
Author(s):  
Zhiguo Li



2018 ◽  
Vol 22 (4) ◽  
pp. 644-664 ◽  
Author(s):  
Jacqueline Pistorello ◽  
David A. Jobes ◽  
Scott N. Compton ◽  
Nadia Samad Locey ◽  
Joseph C. Walloch ◽  
...  




PeerJ ◽  
2021 ◽  
Vol 9 ◽  
pp. e10559
Author(s):  
Xiaobo Zhong ◽  
Bin Cheng ◽  
Xinru Wang ◽  
Ying Kuen Cheung

This article introduces an R package, SMARTAR (Sequential Multiple Assignment Randomized Trial with Adaptive Randomization), by which clinical investigators can design and analyze a sequential multiple assignment randomized trial (SMART) for comparing adaptive treatment strategies. Adaptive treatment strategies are commonly used in clinical practice to personalize healthcare in chronic disorder management. SMART is an efficient clinical design for selecting the best adaptive treatment strategy from a family of candidates. Although some R packages can help in adaptive treatment strategies research, they mainly focus on secondary data analysis for observational studies, instead of clinical trials. SMARTAR is the first R package provides functions that can support clinical investigators and data analysts at every step of the statistical work pipeline in clinical trial practice. In this article, we demonstrate how to use this package, using a real data example.



2015 ◽  
Vol 35 (6) ◽  
pp. 840-858 ◽  
Author(s):  
Semhar B. Ogbagaber ◽  
Jordan Karp ◽  
Abdus S. Wahed




2013 ◽  
Vol 33 (5) ◽  
pp. 760-771 ◽  
Author(s):  
Zhiguo Li ◽  
Marcia Valenstein ◽  
Paul Pfeiffer ◽  
Dara Ganoczy


Biometrics ◽  
2020 ◽  
Author(s):  
Noémi Kreif ◽  
Oleg Sofrygin ◽  
Julie A. Schmittdiel ◽  
Alyce S. Adams ◽  
Richard W. Grant ◽  
...  


2014 ◽  
Vol 23 (6) ◽  
pp. 580-585 ◽  
Author(s):  
Michael P. Wallace ◽  
Erica E. M. Moodie


2017 ◽  
Vol 186 (2) ◽  
pp. 160-172 ◽  
Author(s):  
Elizabeth F Krakow ◽  
Michael Hemmer ◽  
Tao Wang ◽  
Brent Logan ◽  
Mukta Arora ◽  
...  

Abstract Q-learning is a method of reinforcement learning that employs backwards stagewise estimation to identify sequences of actions that maximize some long-term reward. The method can be applied to sequential multiple-assignment randomized trials to develop personalized adaptive treatment strategies (ATSs)—longitudinal practice guidelines highly tailored to time-varying attributes of individual patients. Sometimes, the basis for choosing which ATSs to include in a sequential multiple-assignment randomized trial (or randomized controlled trial) may be inadequate. Nonrandomized data sources may inform the initial design of ATSs, which could later be prospectively validated. In this paper, we illustrate challenges involved in using nonrandomized data for this purpose with a case study from the Center for International Blood and Marrow Transplant Research registry (1995–2007) aimed at 1) determining whether the sequence of therapeutic classes used in graft-versus-host disease prophylaxis and in refractory graft-versus-host disease is associated with improved survival and 2) identifying donor and patient factors with which to guide individualized immunosuppressant selections over time. We discuss how to communicate the potential benefit derived from following an ATS at the population and subgroup levels and how to evaluate its robustness to modeling assumptions. This worked example may serve as a model for developing ATSs from registries and cohorts in oncology and other fields requiring sequential treatment decisions.



Sign in / Sign up

Export Citation Format

Share Document